about
Quality assurance of RNA expression profiling in clinical laboratoriesThe molecular portraits of breast tumors are conserved across microarray platforms.Molecular characterization of human breast tumor vascular cells.A compact VEGF signature associated with distant metastases and poor outcomes.Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay.Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.Clinical implementation of RNA signatures for pharmacogenomic decision-makingBlocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs.Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next-generation Sequencing.High reproducibility using sodium hydroxide-stripped long oligonucleotide DNA microarrays.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.Two FAD3 desaturase genes control the level of linolenic acid in flax seed.Expression of a Brassic napus glutamate 1-semialdehyde aminotransferase in Escherichia coli and characterization of the recombinant protein.An assessment of prognostic immunity markers in breast cancerMolecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast CancerIntegrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
P50
Q26866455-4556DAD1-14B4-4C8A-8A44-5865C1F69BCFQ33241398-0F4C638B-3174-4D59-8D3C-9C72AAC60F4AQ33327647-6440AF8E-657C-43EB-9797-875279A32424Q33418745-D1D5D51B-4490-4F45-86C5-11442BE98503Q35012779-77DD4277-6F3A-4737-AAE8-325EA773E2C5Q35906418-E66DFC3C-9878-4CB3-8BBB-C2CE2B13FD69Q36441512-14C54E1A-B5B3-4619-ADAA-C5DD52342264Q37545050-6E80B4D9-7402-4DEB-97DA-05E328CDBF11Q38991513-7A7F8B06-3407-4141-9E40-D2CC85D8D969Q40464248-D3ECA1B5-72AA-4581-AB52-20F8F0889131Q42466578-388A2FC5-BDC2-48CB-8BCD-A80DC2F460A3Q42665405-1C2C065A-891C-4841-80A9-EF45234F37DFQ44454675-3B34A5A2-B371-4FB3-8C19-E6EB258CFEE8Q58599063-EF1ADE21-42C7-416B-A2D8-D516A5A8DAF3Q59565565-85AA8792-EE0B-4A68-A361-50F9008DC4A6Q64123416-A5352C6F-65B4-463D-B06B-4FC57F15FBED
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Zhiyuan Hu
@ast
Zhiyuan Hu
@en
Zhiyuan Hu
@es
Zhiyuan Hu
@nl
Zhiyuan Hu
@sl
type
label
Zhiyuan Hu
@ast
Zhiyuan Hu
@en
Zhiyuan Hu
@es
Zhiyuan Hu
@nl
Zhiyuan Hu
@sl
prefLabel
Zhiyuan Hu
@ast
Zhiyuan Hu
@en
Zhiyuan Hu
@es
Zhiyuan Hu
@nl
Zhiyuan Hu
@sl
P106
P31
P496
0000-0002-2963-2453